-
4,4′-(1,3-Phenylenedioxy)dianiline 2479-46-1
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-chemistry yezinto ezibonakalayo |Polyimide monomers |
4,4′-(1,3-Phenylenedioxy)dianiline|CAS:2479-46-1 |I-C18H16N2O2
-
4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline 13080-86-9
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial Material Chemistry |Polyimide monomers |4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline |CAS:13080-86-9 |I-C27H26N2O2
-
(S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester 109010-60-8
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Izifo Zenhliziyo |Umfutho Wegazi Ophakeme |S-ATBA |I-CAS:109010-60-8 |I-C16H22N2O3
-
(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate 1423058-53-0
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Izifo ze-Neurologic |Izidakamizwa ze-Antiepileptic |(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate |I-CAS:1423058-53-0 |I-C15H22N2O8
-
I-Lacosamide 175481-36-4
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |Izifo ze-Neurologic |Izidakamizwa ze-Antiepileptic |Lacosamide |CAS:175481-36-4 |I-C13H18N2O3
-
4-(2-Dimethylamino)ethoxybenzylamine 20059-73-8
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial API |Izidakamizwa zesistimu yokugaya |Itopride hydrochloride kanye ne-Intermediates yayo |4-(2-Dimethylamino)ethoxybenzylamine |CAS:20059-73-8 |I-C11H18N2O
-
Itopride 122898-67-3
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial API |Izidakamizwa zesistimu yokugaya |Itopride hydrochloride kanye ne-Intermediates yayo |Itopride |CAS:122898-67-3 |I-C20H26N2O4
-
2-(2-Ethoxyphenoxy)ethyl bromide 3259-03-8
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial API |Izidakamizwa ze-Prostatic Hyperplasia |I-Tamsulosin Hydrochloride Intermediates |CAS:3259-03-8 |I-C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |Izinto ezingavuthiwe |I-Pharmaceutical Intermediates Reagents |I-Industrial API |Izidakamizwa ze-Prostatic Hyperplasia |I-Tamsulosin Hydrochloride Intermediates |I-CAS:116091-63-5 |I-C10H13NO4S
-
4-(4-Phenylbutoxy)benzoic acid 30131-16-9
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |I-Pharmaceutical Intermediates Reagents |Izinto zokusetshenziswa |Izifo zokuphefumula |I-Pranlukast Intermediates |4-(4-Phenylbutoxy)benzoic acid |CAS:30131-16-9 |I-C17H18O3
-
![3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1](https://www.yisunbio.com/uploads/50.jpg)
3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |I-Pharmaceutical Intermediates Reagents |Izinto zokusetshenziswa |Izifo zokuphefumula |I-Pranlukast Intermediates |3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone |I-CAS:136450-06-1 |I-C25H25NO4
-
3′-Amino-2′-hydroxyacetophenone 70977-72-9
Ukukhiqiza kanye nokunikezela nge-biopharmaceutical |I-Pharmaceutical Intermediates Reagents |Izinto zokusetshenziswa |Izifo zokuphefumula |I-Pranlukast Intermediates |3'-Amino-2'-hydroxyacetophenone |CAS:70977-72-9 |C8H9NO2